The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A.
INTRODUCTION
The superfamily of tubulin genes is composed of alpha-, beta-, gamma-, delta-and epsilon families. The alpha and beta families, consisting of at least 15 alpha and 21 beta-tubulin genes, respectively, 1 encode tubulin proteins which form heterodimers as fundamental components of microtubules. 2 Along with microtubule associated proteins (MAPs) and motor proteins on the external surface, tubulin proteins participate in substantial cellular processes of intracellular transport, cell division and neuronal migration. 3, 4 In recent years, an increasing number of tubulin genes were linked to a clinically heterogeneous group of disorders, the "tubulinopathies" (TUBA1A, MIM#602529; TUBA8, MIM#605742; TUBB2A, MIM#615101; TUBB2B, MIM#612850; TUBB3, MIM#602661; TUBB, MIM#191130; TUBG1, MIM#191135). [5] [6] [7] [8] [9] [10] [11] Tubulinopathies are characterized by a broad spectrum of cortical and subcortical malformations and a variety of clinical features. Major cortical anomalies include lissencephaly, polymicrogyria or polymicrogyria-like cortical dysplasia and cortical gyral simplification. Subcortical anomalies affect the corpus callosum, the cerebellar vermis, the brainstem, the basal ganglia and the cerebellum. Further clinical features are microcephaly, developmental delay and epilepsy. 12, 13 To date, TUBA1A
represents the main tubulinopathy gene and accounts for 4-5% of all lissencephaly cases. 14, 15 Using exome analysis in three unrelated individuals with severe developmental delay we identified three heterozygous de novo missense variants in the TUBA1A gene. We extensively reviewed and systematically reanalyzed available public data to provide a standardized synopsis of described variants together with reported neuroradiological and clinical features of TUBA1A-associated tubulinopathy. We used this comprehensive information to perform a detailed analysis of the genotypic and phenotypic spectrum highlighting a possible genotype-phenotype relationship and probable bias in reporting.
MATERIALS AND METHODS

Clinical reports
Individual i084n: A 13-year-old boy was the second child of healthy non-consanguineous parents of European descent and was born at term after an uneventful pregnancy. At age six months, the boy presented with a complex focal seizure and a multifocal infantile cerebral seizure disorder was diagnosed. Anticonvulsive therapy with vigabatrin and valproate was started leading to an initial remission followed by refractory Blitz-Nick-Salaam-like seizures.
Cerebral magnetic resonance imaging (MRI) revealed coarsened cerebral gyri, a hypoplastic rostrum of the corpus callosum, cerebellar vermis hypoplasia, moderately enlarged lateral ventricles and narrowed white matter. At age 4 years severe hypotonia, global developmental delay, spastic movement disorder, strabismus convergens and pyelectasia became apparent. On referral at age 13, he presented with a weight of 41.0 kg (10 th -25 th centile), a height of 146.3 cm (3 rd centile) and an occipitofrontal circumference (OFC) of 52 cm (<3 rd centile). Minor facial features included a flat forehead, low set ears, epicanthic fold, upward slanting palpebral fissures, strabismus, narrow nasal bridge, broad nose tip, short philtrum and an everted lower lip. In addition, a clinodactyly V, a small forefoot and a sandal gap were noticed. Family history and previous genetic workup including chromosome and chromosomal microarray (CMA) were unremarkable.
Individual i085n: A 14.5-year-old boy was the second child of healthy non-consanguineous parents of European descent. He was born at term after an uneventful pregnancy [4170 g (85 th -97 th centile), 55 cm (97 th centile), and OFC 34 cm (10 th -25 th percentile)]. Motor and language milestones were delayed and cerebral MRI revealed mild frontal cortical anomalies, hypoplastic corpus callosum, basal ganglia dysgenesis, ventricular dilatation, accentuated lamina quadrigemina, massive chambered retrocerebellar arachnoidalcyst and a pineal gland cyst. The boy was last seen at age 11.5 years and presented with a weight of 87.6 kg (>97 th centile), height of 172 cm (97 th centile) and head circumference of 56 cm (25 th -50 th percentile). His facial gestalt included a high forehead, large earlobes, epicanthic folds, hypertelorism, jaw deformity, cupid bow shaped upper lip with open mouth appearance, high arched palate and a gap between the upper incisors. Minor features were distally located thumbs, pointed fingers, hallux valgus, and a sandal gap. Family history and previous genetic testing including CMA were unremarkable.
Individual i086n: A 10-year-old girl was the first child of healthy non-consanguineous parents of European descent. She was born at term with parameters in the normal range [3050 g (15 th -40 th centile), 51 cm (75 th -90 th centile), OFC 34 cm (25 th -50 th centile)]. At age six months, a generalized hypotonia and nystagmus were noted followed by developmental regression at 1 year 9 months. Myoclonic and later generalized seizures were treated with anticonvulsive therapy (topiramate, valproate) . Cerebral MRI revealed a Dandy walker malformation, with cerebellar vermis hypoplasia, agenesis of corpus callosum and ventricular dilatation. Further features were fused basal ganglia, and unilateral optic nerve hypoplasia.
At last physical examination (age 9 years 9 months), she presented with a height of 125 cm (<3 rd centile) and head circumference of 50.5 cm (10 th -25 th percentile). Severe language delay with absent speech and muscular hypotonia with spasticity of the legs were noted.
Minor facial features included large ears, hypertelorism, broad flat nasal-bridge, high arched palate, wide spaced teeth, thin lips, short neck, smooth philtrum and a simian crease.
Additional features included proximal located thumbs, pointed fingers, brachymesophalangia V and clinodactyly V. Previous testing including CMA was unremarkable. The identification of the TUBA1A variant in this girl was part of a previous publication without detailed clinical description (reported as ID S_006). 16
Exome Sequencing
Informed written consent was obtained for all participants. The study was approved by the Ethical Committee of the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg. DNA from peripheral blood lymphocytes was extracted using standard methods.
Exome sequencing was performed after SureSelect v5 (i085n, i086n) and v6 (i084n) targeted capturing on HiSeq 2500 for i084n and i085n (Trio analysis 17 ) and i086n (Exome Pool-Seq 16 ).
After mapping of sequence reads to the GRCh37/hg19 reference genome and variant calling using standard methods for the trio analysis 17 or as described by Popp et al. for the exome Pool-Seq 16 , variants in coding regions including splice sites were selected based on population frequency (gnomAD) and computational prediction scores, e.g. CADD score 18 .
Variants were confirmed, and segregation tested by Sanger sequencing.
Review of reported TUBA1A cases from literature and databases
We identified 112 articles, published between 01/2007 and 06/2018, from PubMed applying the search term "TUBA1A". Of these, 28 provided clinical reports and were thus included in this study. All available clinical data was standardized in accordance to terms of the Human Phenotype Ontology (HPO). 19 In contrast to a previously established classification combining cortical and subcortical features like "classic lissencephaly", "lissencephaly with cerebellar hypoplasia", "lissencephaly with agenesis of the corpus callosum" and "centrally predominant pachygyria" 12,20 , we analyzed the features independently. If only the classification was mentioned we used the independent underlying features where HPO terms were available (e.g. "microlissencephaly": microcephaly HP:0000252 + agyria HP:0031882). Nevertheless, we kept composite terms typically used together in the literature such as "agyria-pachygyria" (HP:0031882, HP:0001302) if they affected the same brain structure. Data assessment comprised 11 neuroradiological features, including anomalies of cortical gyration, corpus callosum, brainstem, basal ganglia, internal capsule, cerebellum, cerebellar vermis, hippocampus, ventricular dilatation, 4 th ventricle dilatation, grey matter heterotopia, and other radiological findings. Clinical features included congenital microcephaly, microcephaly, developmental delay, epilepsy, neuro-ophthalmological findings including strabismus and nystagmus, other neurological symptoms including spasticity and muscular hypotonia, and additional features (HPO terms shown in Table 1 , 2 and File S1).
We further included available likely pathogenic or pathogenic variants from ClinVar, 21 denovo-db 22 and DECIPHER 23 . As phenotype information was insufficient in most of these database cases, only variant information was included.
All variants were harmonized to the NM_006009.3 transcript of the GRCh37/hg19 human reference genome based on Human Genome Variation Society (HGVS) recommendations using the Mutalyzer 24 web services. To ensure consistency in the clinical interpretation we independently applied the American College of Medical Genetics and Genomics (ACMG) criteria 25 to all variants with the WGLAB InterVar-tool 26 .
Protein structure analysis of the tubulin alpha-1A variants
Using R and ggplot2 27 we analyzed spatial distribution of all variants in the linear gene model to provide an insight into the variant distribution. Utilizing Pymol (Version 1.8.6.0; Schrödinger, LLC) installed through Conda (Version 4.4.9 build 3.0.27 with Python 2.7.14;
Anaconda Inc.) publicly available tertiary protein structure data of TUBA1A (PDB-ID: J5CO 28 ) was used to classify variants in different groups of potential functional effects as suggested previously. 29 This classification is based on the interaction of the tubulin monomer with neighboring tubulin proteins within the polymer (heterodimer, protofilament, microtubule), with MAPs, or motor proteins. While functional evidence was present for a minority of the variants 5,30 , most mutational effects are based on localization-dependent predictions. As a template we used 51 already classified TUBA1A variants 31 likely affecting the binding of microtubule associated proteins ("MAP binding") or motor proteins, the tubulin folding ("Tubulin folding"), heterodimer and microtubule stability ("Intradimer interaction" and "Longitudinal interaction") the formation of the hollow tubular structure of the microtubule ("Lateral interaction") 32,33 or microtubule dynamics, protein folding and heterodimer stability ("GTP [Guanosintriphosphat] binding") 29, 32 . The specific detrimental effect of variants facing the luminal protein surface ("Lumen facing") is currently unknown.
Computational analyses of TUBA1A missense variant spectrum
We here analyzed the ability of six different computational classifiers (three ensemble scores: CADD, M-CAP, REVEL and the three commonly used scores Polyphen-2, SIFT, MutationTaster) to discriminate pathogenic and neutral population variants by generating all possible missense variants for TUBA1A. First all single base exchanges were generated in the TUBA1A gene region of the GRCh37/hg19 reference (chr12[hg19]:49578578-49583107) as variant call format (VCF) file. These were then annotated with computational scores and databases from dbNSFP 34 version 2.9.3 and variant frequencies from the gnomAD database 35 version 2.0.1 using SnpEff/SnpSift 36 . Missense variants affecting the NM_006009.3 transcript of TUBA1A, excluding variants, which were additionally annotated as potentially affecting splicing, were selected. R language 37 version 3.4.3 with RStudio IDE version 1.1.383 (RStudio, Inc.) with packages from the tidyverse/ggplot2 27 collection were used for plotting and analysis of this variant data provided in the File S1. To analyze possible mutational hotspots, we generated density plots of pathogenic missense variant frequencies reported in the literature and missense variants reported in controls from gnomAD with the "geom_density" function ("adjust" parameter set to 1/4) in ggplot2. To analyze protein regions of higher conservation we plotted all missense variants sorted by amino-acid position with each respective computational score and fitted generalized additive models using the "geom_smooth" function in ggplot2 to produce a smoothed line. Additionally, variants and scores were plotted as scatter and violin plots and two-sided Wilcoxon signed-rank test from the ggsignif package was used to determine whether there was a statistically significant difference between four different missense variant groups ("clinical review", "database", "gnomAD", "simulated"). "Clinical review" included variants from individuals with available phenotype information from our literature review and the three cases reported here, "database" included (likely) pathogenic variants from databases like ClinVar without clinical information, "gnomAD" included all variants present in healthy controls without neurodevelopmental disorders from the gnomAD database, and "simulated" all other possible missense variants in TUBA1A.
Analysis of genotype-phenotype relation
We used the curated set of clinical information and corresponding harmonized variant information to analyze a possible genotype-phenotype relationship by comparing the radiological and clinical features with variant characteristics. We visualized and structured the acquired categorical data into a grid plot using ggplot2 and the tidyverse 27 package for hypothesis formation. Based on this presentation we used the vcd package 38 to analyze the relationship between variant characteristics and clinical data of the individuals by generating mosaic or association plots. As many values in the resulting contingency tables contained values below five, we estimated p-values using a two-sided Fisher's exact test with the "simulate.p.value" setting based on 2,000 replicates in R. One-letter amino-acid nomenclature is used in the resulting plots because of space constrains. 0
RESULTS
Results of exome sequencing in 3 affected individuals
We identified three heterozygous missense variants c.518C>T, c.1307G>A, and c.641G>A in 
Mutational spectrum and distribution of TUBA1A variants
We retrieved a total of 61 distinct variants from 84 born individuals and 20 fetuses from 28 published articles in Pubmed and 59 further distinct variants from databases. 5, 13, 15, 20, 30, Moreover we identified one novel variant c.1307G>A, p.(Gly436Asp), not reported in databases or the literature, in one of the three herein described individuals. Of these 121 distinct variants 119 were missense and two led to a premature stop codon located at the C- Fig. S1 ). Variants in the linear C-terminal region predominantly affect the binding of MAPs or motor proteins. Strikingly, computational scores for the different missense variant groups ("clinical review", "database", "gnomAD", "simulated") mostly showed no significant difference ( Fig. 1D; Fig. S1 ). After mapping of the amino acid residues on the 3D protein structure, we observed that most unique variants in "clinical review" (n=121) are predicted to compromise tubulin folding (34.7%) or possibly affecting the interaction with MAPs or motor proteins, such as kinesins and dyneins (24.8%) ( Fig. 2) . A minority of variants is predicted to affect longitudinal (8.3%), lateral (8.3%) and intradimer (7.4%) interactions, respectively. Finally, 14% of variants are lumen facing and only 2.5% likely affect GTP binding. Considering all assembled variants including the recurrent ones (n=166), the majority (38.6%) is predicted to impair the interaction of MAPs or motor proteins.
Of these, 22 affect the Arg402 position. Variants identified in the three individuals i084n, 
Relation between Genotype and Phenotype
We used the clinical information of the 104 individuals from the "clinical review" group and the herein described three patients (total n=107) to analyze a possible relationship between genotype and phenotype. Individuals with recurrent variants, mostly affecting MAP binding, show a similar phenotype combination in the matrix plot ( Because prenatally diagnosed fetal cases show a more severe phenotype than born individuals, we analyzed a possible contribution of variant characteristics to this observation.
The missense variants reported in fetuses and in born individuals showed no significant difference in structural classification ( Fig. 3B ) and the computational scores did not significantly differ in these two groups (Fig. S3 ). In addition, the structural groups of missense variants were not overrepresented in females or males and the gender was also not associated with prenatal diagnosis (Fig. 3B ).
The visual inspection of the matrix plot ( Fig. 3A; Fig. S4 ) indicated that certain clinical features are enriched in individuals with recurrent variants. Indeed, explorative comparison between missense variants at recurrent and non-recurrent positions confirmed differences in reported clinical features of the individuals carrying these missense variants ( Fig. 3C; Fig.   S5 ). Despite our effort to collect all variants and clinical information described for TUBA1A-associated tubulinopathy, we did not obtain enough data to further analyze the phenotype differences for these variants.
Finally, we observed that individuals with the same variants and similar phenotypes were often reported together (e.g. 
DISCUSSION
In this study, we identified three de novo missense variants in TUBA1A in three individuals with developmental delay and brain malformations. Since the first identification of diseasecausing variants in TUBA1A in 2007 in two affected individuals with cortical dysgenesis, 5 at least 121 distinct heterozygous variants in a total of at least 166 patients including our 3 affected individuals are now described. Our efforts to systematically reanalyze published data enabled insights into the current state of information about TUBA1A-associated tubulinopathy.
Anomalies of the corpus callosum ranging from partial to complete agenesis or hypoplasia are with 96.2% (102/106) the predominantly reported feature of TUBA1A-associated tubulinopathy. Cortical anomalies are the second leading clinical feature reported in 95/96 individuals (99.0%) followed by dysgenesis of the basal ganglia in 58/59 (98.3%). Two of the newly described individuals also presented these features, while individual i086n additionally manifested unilateral optic nerve hypoplasia, a feature predominantly linked to TUBA8associated tubulinopathy 6 but also present in 7/35 (20.0%) of individuals with TUBA1Aassociated tubulinopathy.
Analysis of the type and localization of all possible 2,969 missense variants from the simulation showed that the large majority of TUBA1A missense variants are predicted to be deleterious (CADD ≥ 20: 84.2%, M-CAP ≥ 0,025: 98.0%, REVEL ≥ 0,5: 78.8%; Fig. 1D ). This is in agreement with an ExAC Z-score 35 of 6.23, confirming that TUBA1A is extremely depleted of missense variants in the general population. This resulted in high computational prediction scores independent of causality. Thus, variants might be reported to be pathogenic (ACMG class 5) despite relatively low computational scores and variants found in healthy controls might have scores above the recommended respective thresholds (Fig. 1D ).
After analyzing the relation of three ensemble computational prediction scores and expected pathogenicity, we concluded that computational prediction scores are of limited utility for predicting pathogenicity in TUBA1A. We suggest that segregation with the disease in the family or de novo occurrence, two major criteria of the ACMG guidelines for variant interpretation, are more appropriate for variant classification.
Based on the observation of the mutational distribution we analyzed a possible relationship between genotype and phenotype. We observed clustering of disease causing variants in the region around the amino acid residue Arg402 ( Fig. 1A-C, Fig S2) . The residue Arg402 is located in the interaction site of various MAPs or motor proteins 30 which are involved in different processes including the polymerization and stabilization of microtubules and intracellular vesicle transport. 69 Defects in some MAPs or motor proteins result in a similar clinical spectrum as observed for specific MAP-associated TUBA1A variants. 30, 70 Overall, variants of the Arg402 residue and other specific recurrent variants, which are predominantly MAP interacting, were previously associated with overlapping neuro-radiological features. 13, 30 Indeed, we could show a non-uniform distribution for reported clinical features and the recurrent variants ( Fig. 3C ), indicating a possible genotype-phenotype relation. This observation might in part be attributed to detailed structured morphological categorization of brain anomalies used by different authors and individual preferences for certain terms. In addition, difficulties in the interpretation of the radiographic cortical and subcortical anomalies or technical differences in brain imaging could represent a possible confounder. Of note, recurrent variants with similar phenotype combinations were often reported by the same authors indicating a possible observational bias ( Fig. 3D ), thus limiting the interpretation of these genotype-phenotype relations. Another problem hindering a more detailed investigation is the high degree of missing data we recognized for several phenotypic categories. The directed acyclic graphs structure of HPO allows grouping of specialized terms into less specialized parent terms. Future development of algorithms comparing the phenotypic similarity between groups of individuals with the same or functionally similar pathogenic variants might alleviate some of these problems and allow further characterization of variant specific phenotypes. However, some of these endeavors could be hampered by the difficulty to distinguish between missing information and normal phenotype in published reports. This is especially problematic as HPO describes "phenotype abnormalities" but has no terms for normal phenotypes. We propose standardization in clinical reporting of rare disease cases based on expert recommendations with a minimal scheme covering disease specific phenotypes.
Even though TUBA1A-associated tubulinopathy is the most common tubulinopathy form, our results indicate that more clinical and mutational information is necessary to evaluate a potential genotype-phenotype correlation. This became apparent in fetuses, where we and others observed the most severe phenotypic spectrum compared to born cases. 13, 20 This could not be explained by specific properties of the identified variants ( Fig. 3B, Fig. S3 ). We therefore propose that additional variants in other genes or random developmental processes in cellular pathways in the respective individuals are underlying the phenotypic variability. Genome wide and functional studies might help to allow further characterization into specific clinical groups.
CONCLUSION
Our systematic reanalysis of published clinical data allowed an explorative investigation of a genotype-phenotype relationship. We found an enrichment of specific radiological features in recurrent variants; however, insufficient data availability, data variability and a possible observer bias were limiting factors for possible associations. A thoroughly conducted clinical examination and the standardized reporting of phenotype and genotype information in online databases, e.g. ClinVar 21 and LOVD 71 are fundamental for the systematic analysis of rare diseases such as TUBA1A-associated tubulinopathy. DECIPHER for a total of 59 variants), healthy controls ("gnomAD": 9 variants) and all other possible missense variants ("simulated": 2841 variants) (see also Fig. S1 B) . 
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